Citation:
胡毅,刘兵,杨旭. 血清CEA、CA242、CA19-9及其联检对大肠癌的诊断价值. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2007, 14(6): 700-700. doi:
Copy
Copyright © the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
1. |
Junsela P, Haglund C, Robert PJ. Compation of a new tumor marker CA242 with CA19-9, CA50 and CEA in digestive tract disease [J]. Br J Cancer, 1991; 63(4)∶636.
|
2. |
王继东, 高峰. 消化系肿瘤患者中CA19-9的微粒子酶免疫法检测 [J]. 上海免疫学杂志, 1997; 17(1)∶57.
|
3. |
吴健雄, 余宏迢, 绍永孚, 等. CEA和CA242在结直肠癌中的诊断意义 [J]. 中华肿瘤杂志, 1995; 17(6)∶438.
|
- 1. Junsela P, Haglund C, Robert PJ. Compation of a new tumor marker CA242 with CA19-9, CA50 and CEA in digestive tract disease [J]. Br J Cancer, 1991; 63(4)∶636.
- 2. 王继东, 高峰. 消化系肿瘤患者中CA19-9的微粒子酶免疫法检测 [J]. 上海免疫学杂志, 1997; 17(1)∶57.
- 3. 吴健雄, 余宏迢, 绍永孚, 等. CEA和CA242在结直肠癌中的诊断意义 [J]. 中华肿瘤杂志, 1995; 17(6)∶438.